Adding drama to the ongoing bid for Nan Shan Life Insurance Co (南山人壽), a consortium of Goldsun Development & Construction Co (國產實業), Taiwan Secom Co (中興保全) and Hong Kong’s Primus Financial Holding Co (博智金融) has offered joint governance with Nan Shan’s US parent, American International Group Inc (AIG).
The offer marks the latest attempt by a potential buyer to secure AIG’s 97.57 percent stake in Nan Shan, as the US firm has yet to select a bidder after putting its Taiwanese unit back on the market.
“By offering to jointly run Nan Shan, we hope to find a solution acceptable to AIG and the Financial Supervisory Commission,” Taiwan Secom spokesman Max Chu (朱漢光) said by telephone.
The commission has repeatedly called on AIG to retain Nan Shan and has promised to provide the necessary measures to stabilize the industry and protect the rights of Nan Shan employees and policyholders.
The consortium, which is set to establish a holding company in the next few days for the purpose of the acquisition, has pledged to employ all Nan Shan executives and staffers and keep their salary and benefits intact for at least two years, Chu said.
While willing to share governance, Goldsun, a cement maker, and Taiwan Secom, a home security supplier, would like to have a majority stake in Nan Shan, Chu said. Both Goldsun and Taiwan Secom are controlled by Lin Shiaw-shin (林孝信) and his family.
“Taiwan Secom has long planned to own an insurance unit,” Chu said. “By offering to join forces with AIG, the consortium should be able to pass the professional competence requirement.”
The commission has required Nan Shan buyers to demonstrate a long-term commitment, the capability to increase capital and competence in professional management.
“The consortium intends to trade Nan Shan shares on the local bourse to meet recapitalization needs in the future,” Chu said.
The consortium will also agree to return all statutory reserves as required by the Nan Shan’s union, Chu said.
AIG has yet to respond to the co-governance proposal, Chu said, adding that Primus is negotiating the matter on the consortium’s behalf.
The financial regulator declined to comment except to reiterate the five review principles under which the buyer must also obey funding rules, especially if Chinese capital is involved.
Wu Chung-chuang (吳崇權), deputy director-general of the commission’s insurance bureau, said the financial regulator has not heard from AIG since a visit before Christmas.
“We cannot say anything before AIG files new share transfer applications,” Wu told an evening media briefing.
The consortium is vying for Nan Shan with four other contenders: Cathay Financial Holding Co (國泰金控), Fubon Financial Holding Co (富邦金控), Chinatrust Financial Holding Co (中信金控) and a consortium comprised of Ruentex Group (潤泰集團) and footwear maker Pou Chen Corp (寶成工業).
Just a few years ago, the millennial generation — generally defined as those born from the early 1980s through the mid-1990s — was synonymous with youthful rebellion. However, now, as the millennials ease into early middle age, they are finding their path out of their parents’ basement to be a lot harder than it was for earlier generations. The fundamental problem is that millennials are not building wealth. The wealth of the median US household headed by someone 35 or younger has actually shrunk in inflation-adjusted terms since the mid-2000s, even as the wealth of older Americans has continued to grow. An
Gogoro Inc (睿能創意) yesterday launched its first electric bicycle, the Gogoro Eeyo 1, in Taiwan, after unveiling the bike in New York in late May and in France on Tuesday. The company said it would also introduce the series in other European countries such as Germany and the Netherlands. The “Eeyo project” is the fourth of Gogoro’s eight projects that concentrate on smart transportation, which includes Gogoro’s electric scooter, battery swap system and electric scooter sharing service, company founder and chief executive officer Horace Luke (陸學森) told a media briefing in Taipei. “There are various types of city commuters. We will not
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price
NOT A PANACEA: Offering 5G services would not solve the problem of declining telecom incomes, chairman Sheih Chi-mau said, expecting a flat 5G telecom revenue Chunghwa Telecom Co (中華電信) yesterday became the nation’s first telecom to debut its 5G services, offering tiered tariffs that include a threshold of NT$599 and flat rates, as it aims to switch half of its subscribers to the 5G network within three years. Subscribers would have unlimited data transmission for monthly fees starting at NT$1,399 — the same flat rate as when the company launched its 4G service in 2014 — and they can subscribe to the highest-rate plan for NT$2,699 per month for faster data transmission speeds and larger bandwidth, the company said. Data transmission speeds would be within the range